Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Apple
AAPL
|
+$3.05B |
| 2 |
Broadcom
AVGO
|
+$1.54B |
| 3 |
NVIDIA
NVDA
|
+$1.43B |
| 4 |
Microsoft
MSFT
|
+$1.3B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.66B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.21B |
| 3 |
Imperial Oil
IMO
|
+$797M |
| 4 |
Vale
VALE
|
+$561M |
| 5 |
Canadian Natural Resources
CNQ
|
+$543M |
Sector Composition
| 1 | Technology | 23.76% |
| 2 | Financials | 9.79% |
| 3 | Healthcare | 8.86% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Industrials | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4426
Priority Technology Holdings
PRTH
$602M
| $107K | ﹤0.01% |
20,307
+4,920
| +32% | +$26K |
|
4427
Torrid Holdings
CURV
$179M
| $107K | ﹤0.01% |
14,257
-4,668
| -25% | -$35K |
|
4428
Marchex
MCHX
$88.4M
| $105K | ﹤0.01% |
67,933
+4
| +0% | +$6 |
|
4429
Renovaro
RENB
$47.8M
| $103K | ﹤0.01% |
59,079
-247,065
| -81% | -$432K |
|
4430
INmune Bio
INMB
$46.8M
| $103K | ﹤0.01% |
11,657
-75,948
| -87% | -$670K |
|
4431
Byrna Technologies
BYRN
$471M
| $102K | ﹤0.01% |
10,194
-105,855
| -91% | -$1.06M |
|
|
AEVA
4432
Aeva Technologies
AEVA
$805M
| $101K | ﹤0.01% |
+40,020
| New | +$101K |
|
|
TVRD
4433
Tvardi Therapeutics, Inc. Common Stock
TVRD
$308M
| $101K | ﹤0.01% |
10,824
+9,389
| +654% | +$87.2K |
|
4434
X4 Pharmaceuticals
XFOR
$76.1M
| $99.3K | ﹤0.01% |
5,706
-29,592
| -84% | -$515K |
|
|
NEXN
4435
Nexxen International
NEXN
$606M
| $98.9K | ﹤0.01% |
17,605
-17
| -0.1% | -$96 |
|
4436
United Security Bancshares
UBFO
$166M
| $98.7K | ﹤0.01% |
13,613
+33
| +0.2% | +$239 |
|
4437
Ovid Therapeutics
OVID
$88.9M
| $97.6K | ﹤0.01% |
126,826
+67,842
| +115% | +$52.2K |
|
|
CMAX
4438
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $94.3K | ﹤0.01% |
+33,800
| New | +$94.3K |
|
4439
Kingsway Financial Services
KFS
$407M
| $91.9K | ﹤0.01% |
11,157
-4,744
| -30% | -$39.1K |
|
4440
WM Technology
MAPS
$131M
| $89K | ﹤0.01% |
85,568
+16,918
| +25% | +$17.6K |
|
|
HSAI
4441
Hesai Group
HSAI
$3.71B
| $88.4K | ﹤0.01% |
21,106
+9,106
| +76% | +$38.2K |
|
4442
Cellectar Biosciences
CLRB
$16M
| $87.5K | ﹤0.01% |
+1,167
| New | +$87.5K |
|
4443
Foghorn Therapeutics
FHTX
$291M
| $87.4K | ﹤0.01% |
15,194
+3,773
| +33% | +$21.7K |
|
4444
Senseonics Holdings
SENS
$357M
| $85K | ﹤0.01% |
+213,092
| New | +$85K |
|
4445
Ceragon Networks
CRNT
$180M
| $83.6K | ﹤0.01% |
33,421
-113,219
| -77% | -$283K |
|
|
YSG
4446
Yatsen Holding
YSG
$959M
| $83K | ﹤0.01% |
+31,199
| New | +$83K |
|
|
ONCY
4447
Oncolytics Biotech
ONCY
$133M
| $82.8K | ﹤0.01% |
83,598
| – | – |
|
4448
ProShares UltraShort FTSE Europe
EPV
$16.1M
| $82.7K | ﹤0.01% |
+2,147
| New | +$82.7K |
|
4449
Gaia
GAIA
$146M
| $82.4K | ﹤0.01% |
18,677
+19
| +0.1% | +$84 |
|
|
OCEA
4450
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
| $79.3K | ﹤0.01% |
+64,985
| New | +$79.3K |
|